Truqap Tablet, Film Coated
Product Images NDC 0310-9501

5 FDA label images from Astrazeneca Pharmaceuticals Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Truqap (NDC 0310-9501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chem Structure)

Chemical Structure (Chem Structure)
Chemical structure of capivasertib showing its molecular framework including an amide group, a chlorophenyl ring, and multiple nitrogen-containing heterocycles.*
FDA Label Image

Figure_1 (Figure 1)

Figure_1 (Figure 1)
A Kaplan-Meier plot showing the probability of progression-free survival over time (months) comparing TRUQAP (capivasertib) plus Fulvestrant against Placebo plus Fulvestrant. The graph includes a risk table below with the number of patients at risk for each treatment group at different time points up to 24 months.*
FDA Label Image

Figure_2 (Figure 2)

Figure_2 (Figure 2)
A Kaplan-Meier survival curve showing the probability of radiographic progression-free survival over time from randomization (months) comparing TRUQAP (capivasertib) plus Abiraterone versus placebo plus Abiraterone. The graph includes patient numbers at risk at various time points up to 45 months.*
FDA Label Image

160mg_label (Abel 160mg)

160mg_label (Abel 160mg)
The image shows a label for TRUQAP (capivasertib) tablets, 160 mg strength, film-coated tablets. The label indicates a package containing 64 tablets. It includes the NDC number 0310-9500-01, a barcode, and manufacturer information by AstraZeneca Pharmaceuticals LP. The label also provides storage instructions and prescription-only designation.*
FDA Label Image

200mg_label (Label 200mg)

200mg_label (Label 200mg)
TRUQAP (capivasertib) 200 mg film-coated tablets packaging label displaying 64 tablets. The label includes NDC 0310-9501-01 and notes AstraZeneca Pharmaceuticals LP as the labeler. The label highlights storage instructions and specifies oral administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.